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Introduction
Polyketides form the basic building blocks of numerous natural products, which are in use in pharmaceuticals, food additives and other fine chemicals. 
Many of these polyketides possess very specific cyclic and aromatic conformations. The programmable platform we aim to create will be able to 
efficiently and directly produce a vast array of polyketide derived compounds. The platform will be integrated in a well known heterologous host to 
improve the predictability and engineering options of the platform.
The basic platform will allow production of polyketides of different lengths and folding patterns. The biosynthesis of the polyketides is divided into 
different steps and by swapping either domains between enzymes or whole enzymes between pathways the length of the polyketides or the individual 
folding pattern can be directed towards a desired product. Further development of the platform will be combinations of more enzymes to enlarge the 
possible chemical diversity of the platform.
Polyketide synthesis
The synthesis of the polyketide backbone is 
carried out by polyketide synthases. These 
can have many different origins, but we 
have focused on synthases from type I and 
III PKS systems. The goal is to make non-
reduced polyketide backbones, which can 
then subsequently be modified by other 
enzyme types included in the platform.
Polyketide folding
After the backbone has been formed the 
next step in the platform is the folding of 
the backbone into a cyclic and aromatic 
system. Each polyketide backbone can be 
folded in many different polyketide 
scaffolds depending on the chosen 
foldase. Thus one backbone can lead to 
many different scaffolds.
Further chemodiversity
The formed polyketide scaffolds can be 
further modified to yield greater chemo-
diversity. This can be done e.g. via specific 
methylation or amination, or via reduction 
or oxidation of the initial scaffold. The final 
number of products, which this platform will 
be able to produce, is only limited to the 
number of enzymes, which are included.
Cell factories
The host organism for this platform will be heterologous to ensure a platform with a high degree of 
predictability and great engineering options. We are currently working with both Escherichia coli and 
Saccharomyces cerevisiae as both of these organisms are well characterized,  easy to cultivate, offer many 
genetic tools and little background chemistry to interfere with our platform. 
Many systems for genetic engineering exists for both organisms. In E. coli expression with the Duet vectors 
from Novagen® allows for combination of up to eight genes in a single strain [1], leading to fast strain 
construction and combination of many different enzymes.  In yeast, defined integration sites currently 
allow for chromosomal integration of up to 14 genes [2],  with possibility of elevated expression via the 
CASCADE system [3].
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